Literature DB >> 27598936

[Maternal-fetal transmission of Trypanosoma cruzi, a health problem slightly studied in Mexico: case Chiapas].

Guillermina Campos-Valdez, Luis Miguel Canseco-Ávila, Fernando González-Noriega, Oscar Alfaro-Zebadua, Ismael Yadird Nava-Medecigo, Enedina Jiménez-Cardoso.   

Abstract

OBJECTIVE: To determine the Trypanosoma cruzi infection prevalence in 1125 pregnant women and the transmission frequency to their children from Tapachula and Palenque, Chiapas.
MATERIALS AND METHODS: We determined the prevalence by serology tests and the transmission frequency by polymerase chain reaction (PCR) and T. cruzi reactivity capacity after 12 months.
RESULTS: Total maternal infection prevalence were 23/1 125 (2.04%), 9/600 (1.5%) were from Tapachula and 14/525 (2.6%) from Palenque. The seropositive women were between 20 and 35 years old, 31.8% have Premature Rapture of Membrane and 9.1% have history of perinatal death. The total percentage of positive newborns by PCR was 9/23 (39.13%), out of those 2/9 (22.2%) are from Tapachula and 7/14 (50%) from Palenque. The Maternal Fetal transmission frequency was. 2/9 (22.2%) in Tapachula and 1/14 (7.14%) in Palenque, all positive infants were asynthomatic.
CONCLUSION: The maternal-fetal transmission rate in Chiapas State is variable; the reason could be the maternal immunological status and T. cruzi strain.

Entities:  

Mesh:

Year:  2016        PMID: 27598936

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  2 in total

1.  Aleatory Trypanosoma cruzi Vertical Transmission in Chiapas, Mexico: A Case Report.

Authors:  Sury Antonio López-Cancino; Jorge Fernando Méndez-Galván; Mariana Soria-Guerrero; Marcos Meneses-Mayo; Sergio Agustin Islas-Andrade; Enedina Jiménez-Cardoso
Journal:  Iran J Parasitol       Date:  2021 Oct-Dec       Impact factor: 1.012

2.  Trypanosoma cruzi infection in puerperal women and their neonates at Barcelona, Anzoategui State, Venezuela

Authors:  Norielis Del Carmen Zabala; Mariolga Berrizbeitia; Alicia Jorquera; Jessicca Rodríguez; Leomery Romero
Journal:  Biomedica       Date:  2019-12-01       Impact factor: 0.935

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.